John Krupinski
6Patents
4h-index
7Co-inventors
42Inventor score
Filing activity: Oct 23, 2015 → Dec 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9434778B2 | Modified FGF-21 polypeptides comprising an internal deletion and uses thereof | Chemistry; Metallurgy | 17 | Active |
| US9631004B2 | Modified FGF-21 polypeptides comprising an internal deletion and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US10189883B2 | Therapeutic uses of modified FGF-21 polypeptides | Chemistry; Metallurgy | 9 | Active |
| US10377806B2 | Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US11248031B2 | Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides | Chemistry; Metallurgy | 2 | Active |
| US12247058B2 | Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.